ReviewNature reviews. Clinical oncology2018
Targeting the IL-6/JAK/STAT3 signalling axis in cancer.
Daniel E Johnson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1,917 papers cite itlatest 60 shown
this paperpooled ittrialcites it